Squarepoint Ops LLC - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 267 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2020. The put-call ratio across all filers is 0.63 and the average weighting 0.2%.

Quarter-by-quarter ownership
Squarepoint Ops LLC ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$515,797
-70.9%
19,196
-61.4%
0.00%
-80.0%
Q2 2023$1,773,514
-63.8%
49,734
-74.2%
0.01%
-75.0%
Q1 2023$4,894,224
+1843.4%
192,686
+3003.3%
0.02%
+1900.0%
Q4 2022$251,837
+5.4%
6,209
-14.0%
0.00%0.0%
Q3 2022$239,000
-95.0%
7,223
-94.7%
0.00%
-96.3%
Q2 2022$4,799,000
+427.4%
136,295
+588.6%
0.03%
+575.0%
Q1 2022$910,000
+109.2%
19,793
+184.3%
0.00%
+300.0%
Q3 2021$435,000
-15.7%
6,961
+11.8%
0.00%
-50.0%
Q2 2021$516,000
-43.3%
6,229
-70.5%
0.00%
-83.3%
Q3 2020$910,000
-16.0%
21,134
-15.7%
0.01%
-33.3%
Q2 2020$1,083,000
-44.7%
25,072
-63.1%
0.02%
-64.0%
Q1 2020$1,957,000
+353.0%
68,020
+898.7%
0.05%
+1566.7%
Q4 2019$432,000
+14.6%
6,811
-49.1%
0.00%0.0%
Q3 2019$377,000
-36.9%
13,385
-40.5%
0.00%
-50.0%
Q2 2019$597,000
-64.1%
22,510
-75.2%
0.01%
-66.7%
Q1 2019$1,664,000
+740.4%
90,654
+468.4%
0.02%
+800.0%
Q4 2018$198,000
+5.3%
15,949
-68.8%
0.00%
-33.3%
Q4 2017$188,000
+164.8%
51,200
+212.2%
0.00%
+200.0%
Q3 2017$71,000
+44.9%
16,400
-46.0%
0.00%0.0%
Q2 2017$49,000
+63.3%
30,398
+57.2%
0.00%0.0%
Q4 2016$30,00019,3400.00%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q3 2020
NameSharesValueWeighting ↓
WESTERN FINANCIAL Corp 820,346$62,945,00041.38%
Johnson & Johnson Innovation - JJDC, Inc. 3,260,869$250,206,00032.27%
Aquilo Capital Management, LLC 365,926$28,078,0005.84%
L1 Capital Pty Ltd 298,687$23,127,0004.32%
First Light Asset Management, LLC 704,449$54,052,0004.00%
ACUTA CAPITAL PARTNERS, LLC 139,000$10,665,0002.90%
Evolutionary Tree Capital Management, LLC 48,265$3,703,0002.82%
Parkman Healthcare Partners LLC 127,171$9,758,0002.50%
Capital Impact Advisors, LLC 88,183$6,766,0001.66%
Tri Locum Partners LP 56,003$4,297,0001.56%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders